Eli Lilly, the pharmaceutical company developing retatrutide, has progressed the compound into Phase 3 clinical trials, which are evaluating its efficacy and safety in larger populations across multiple indications, including obesity and type 2 diabetes
they work best with lifestyle changes like a healthy diet and regular exercise
Telehealth company Ro on Wednesday launched a new tracker to help patients find a popular class of weight loss and diabetes drugs called GLP-1s amid shortages of those treatments in the U.S
Telehealth platforms like ours offer a more streamlined experience
Tirzepatide Tirzepatide, a novel dual agonist of GIP and GLP-1 receptors, has demonstrated exceptional efficacy in improving glycemic control and promoting weight loss in individuals with Type 2 diabetes mellitus (T2DM) and obesity (43)
Its the rapid weight loss that triggers the shedding, not the medication directly damaging your hair follicles